Human BAFF/BlyS/TNFSF13B ELISA Kit |
RK00402 |
Abclonal |
96 Tests |
EUR 625.2 |
Baff Elisa Laboratories manufactures the human baff/blys/tnfsf13b quantikine elisa kit reagents distributed by Genprice. The Human Baff/Blys/Tnfsf13B Quantikine Elisa Kit reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact baff elisa. Other Human products are available in stock. Specificity: Human Category: Baff/Blys/Tnfsf13B Group: Quantikine Elisa
Recombinant Human BLyS/ TNFSF13B/ BAFF Protein, Untagged, E.coli-5ug |
EnQuireBio |
5ug |
EUR 184.8 |
Human BAFF/TNFSF13B ELISA Kit |
EnoGene |
96T |
EUR 1000 |
BAFF (BLyS) Protein |
Abbexa |
-
EUR 5388.00
-
EUR 393.60
-
EUR 276.00
|
|
|
BAFF (BLyS) Protein |
Abbexa |
-
EUR 6991.20
-
EUR 393.60
-
EUR 276.00
|
|
|
BLyS Antibody / BAFF |
NSJ Bioreagents |
100 ug |
EUR 356.15 |
Description: BLyS / BAFF was regularly detected by enzyme-linked immunosorbent assay in brain tissue lysates and in normal spinal fluid, and in astrocytes by double fluorescence microscopy. BAFF was localized in astrocytes close to BAFF-R-expressing immune cells. BAFF receptors were strongly expressed in situ in primary central nervous system (CNS) lymphomas. The TNF superfamily member B cell-activating factor (BAFF) plays an important role in humoral immunity and in autoimmune diseases, including RA. Local BAFF gene targeting inhibited proinflammatory cytokine expression, suppressed generation of plasma cells and Th17 cells, and markedly ameliorated joint pathology. The B cell activating factor BAFF (BlyS/TALL-1/zTNF4) is a tumor necrosis factor (TNF)-related ligand that promotes B cell survival and binds to three receptors (BCMA, TACI, and the recently described BAFF-R). |
BAFF Antibody / BLyS |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: BAFF/BLyS/CD257 is a type II transmembrane protein, and a member of the tumor necrosis factor ligand superfamily. It is proteolytically cleaved to form a soluble protein. BAFF, like other TNF ligand family members, forms homo-trimers. The predicted molecular weight of a BAFF monomer is approximately 31kDa. It is expressed on peripheral blood B and T lymphocytes, monocytes, macrophages, and dendritic cells and is upregulated by IFN-gamma and down-regulated by PMA/ionomycin treatment. BAFF stimulates B and T cell immunity and regulates humoral immunity by binding TACI and BCMA receptors; BAFF prevents apoptosis and promotes B cell survival by binding the BAFF-specific receptor (BAFFR/BR3). |
BAFF Antibody / BLyS |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: BAFF/BLyS/CD257 is a type II transmembrane protein, and a member of the tumor necrosis factor ligand superfamily. It is proteolytically cleaved to form a soluble protein. BAFF, like other TNF ligand family members, forms homo-trimers. The predicted molecular weight of a BAFF monomer is approximately 31kDa. It is expressed on peripheral blood B and T lymphocytes, monocytes, macrophages, and dendritic cells and is upregulated by IFN-gamma and down-regulated by PMA/ionomycin treatment. BAFF stimulates B and T cell immunity and regulates humoral immunity by binding TACI and BCMA receptors; BAFF prevents apoptosis and promotes B cell survival by binding the BAFF-specific receptor (BAFFR/BR3). |
Quantikine Elisa information
Human B-Cell Activating Factor / BAFF / CD257 (TNFSF13B) ELISA Kit |
abx050009-96tests |
Abbexa |
96 tests |
EUR 924 |
|
Recombinant (E.Coli) Human BAFF/CD257 (BLYS, TALL1, THANK, TNFSF20) protein |
RP-1619 |
Alpha Diagnostics |
5 ug |
EUR 343.2 |
Active Recombinant human TNFSF13B/BAFF/CD257 Protein |
RP01730 |
Abclonal |
100μg |
EUR 65 |
|
Recombinant Human BAFF/TNFSF13B Protein, Fc His Tag |
E40KMP1245 |
EnoGene |
20ug |
EUR 495 |
Recombinant Human BAFF/TNFSF13B Protein, Fc His Tag |
E40KMP2160 |
EnoGene |
20ug |
EUR 495 |
BAFF / TNFSF13B / CD257 Recombinant Protein |
11-391 |
ProSci |
0.05 mg |
EUR 714.3 |
Description: B-cell activating factor (BAFF) is also known as tumor necrosis factor ligand superfamily member 13B , TNFSF13B, BAFF, B Lymphocyte Stimulator (BLyS) , cluster of differentiation 257 (CD257), DTL, TNF- and APOL-related leukocyte expressed ligand (TALL-1), THANK, TNFSF20, ZTNF4, and is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This cytokine is a ligand for receptors TNFRSF13B/TACI, TNFRSF17/BCMA, and TNFRSF13C/BAFFR. This cytokine is expressed in B cell lineage cells, and acts as a potent B cell activator. It has been also shown to play an important role in the proliferation and differentiation of B cells. It is expressed as transmembrane protein on various cell types including monocytes, dendritic cells and bone marrow stromal cells. BAFF is the natural ligand of three unusual tumor necrosis factor receptors named BAFF-R, TACI, and BCMA, all of which have differing binding affinities for it. These receptors are expressed mainly on mature B lymphocytes (TACI is also found on a subset of T-cells and BCMA on plasma cells). TACI binds worst since its affinity is higher for a protein similar to BAFF, called a proliferation-inducing ligand (APRIL). BCMA displays an intermediate binding phenotype and will work with either BAFF or APRIL to varying degrees. Signaling through BAFF-R and BCMA stimulates B lymphocytes to undergo proliferation and to counter apoptosis. All these ligands act as heterotrimers (i.e. three of the same molecule) interacting with heterotrimeric receptors, although BAFF has been known to be active as either a hetero- or homotrimer. BAFF acts as a potent B cell activator and has been shown to play an important role in the proliferation and differentiation of B cells. |
BAFF / TNFSF13B / CD257 Recombinant Protein |
11-518 |
ProSci |
0.1 mg |
EUR 714.3 |
Description: B-cell activating factor (BAFF) is also known as tumor necrosis factor ligand superfamily member 13B , TNFSF13B, BAFF, B Lymphocyte Stimulator (BLyS) , cluster of differentiation 257 (CD257), DTL, TNF- and APOL-related leukocyte expressed ligand (TALL-1), THANK, TNFSF20, ZTNF4, and is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This cytokine is a ligand for receptors TNFRSF13B/TACI, TNFRSF17/BCMA, and TNFRSF13C/BAFFR. This cytokine is expressed in B cell lineage cells, and acts as a potent B cell activator. It has been also shown to play an important role in the proliferation and differentiation of B cells. It is expressed as transmembrane protein on various cell types including monocytes, dendritic cells and bone marrow stromal cells. BAFF is the natural ligand of three unusual tumor necrosis factor receptors named BAFF-R, TACI, and BCMA, all of which have differing binding affinities for it. These receptors are expressed mainly on mature B lymphocytes (TACI is also found on a subset of T-cells and BCMA on plasma cells). TACI binds worst since its affinity is higher for a protein similar to BAFF, called a proliferation-inducing ligand (APRIL). BCMA displays an intermediate binding phenotype and will work with either BAFF or APRIL to varying degrees. Signaling through BAFF-R and BCMA stimulates B lymphocytes to undergo proliferation and to counter apoptosis. All these ligands act as heterotrimers (i.e. three of the same molecule) interacting with heterotrimeric receptors, although BAFF has been known to be active as either a hetero- or homotrimer. BAFF acts as a potent B cell activator and has been shown to play an important role in the proliferation and differentiation of B cells. |
CD257 / BAFF / TNFSF13B (C257/1638) Antibody |
BNC941638-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD257 / BAFF / TNFSF13B (C257/1638),CF594 conjugate, Concentration: 0.1mg/mL |
CD257 / BAFF / TNFSF13B (C257/1638) Antibody |
BNC941638-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD257 / BAFF / TNFSF13B (C257/1638),CF594 conjugate, Concentration: 0.1mg/mL |
CD257 / BAFF / TNFSF13B (C257/1638) Antibody |
BNC801638-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD257 / BAFF / TNFSF13B (C257/1638),CF680 conjugate, Concentration: 0.1mg/mL |
CD257 / BAFF / TNFSF13B (C257/1638) Antibody |
BNC801638-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD257 / BAFF / TNFSF13B (C257/1638),CF680 conjugate, Concentration: 0.1mg/mL |
CD257 / BAFF / TNFSF13B (C257/1638) Antibody |
BNC701638-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD257 / BAFF / TNFSF13B (C257/1638),CF770 conjugate, Concentration: 0.1mg/mL |
CD257 / BAFF / TNFSF13B (C257/1638) Antibody |
BNC701638-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD257 / BAFF / TNFSF13B (C257/1638),CF770 conjugate, Concentration: 0.1mg/mL |
CD257 / BAFF / TNFSF13B (C257/1638) Antibody |
BNC811638-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD257 / BAFF / TNFSF13B (C257/1638),CF680R conjugate, Concentration: 0.1mg/mL |
CD257 / BAFF / TNFSF13B (C257/1638) Antibody |
BNC811638-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD257 / BAFF / TNFSF13B (C257/1638),CF680R conjugate, Concentration: 0.1mg/mL |
CD257 / BAFF / TNFSF13B (C257/1638) Antibody |
BNC881638-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD257 / BAFF / TNFSF13B (C257/1638),CF488A conjugate, Concentration: 0.1mg/mL |
CD257 / BAFF / TNFSF13B (C257/1638) Antibody |
BNC881638-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD257 / BAFF / TNFSF13B (C257/1638),CF488A conjugate, Concentration: 0.1mg/mL |